{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:40:30Z","timestamp":1778852430398,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a dysimmune disease primarily targeting the Schwann cell myelin sheath in the peripheral nervous system (PNS), resulting in sensorimotor deficits. Surprisingly, subtle cognitive impairments as well as axonal damage, indicated by elevated serum neurofilament light chain (sNfL), prevail in CIDP. This study investigated whether elevated sNfL is associated with lower cognitive performance in CIDP.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Thirty-five CIDP patients underwent digital cognitive testing across multiple domains, alongside assessments of sociodemographic, clinical, and sNfL measures. Patients were stratified into low- and high-sNfL groups based on the median value, and clinical variables were compared. Further, general linear models, controlled for clinical and sociodemographic factors, were employed to evaluate the predictive value of sNfL for global and domain-specific cognitive functioning.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Higher sNfL values were associated with worse general cognitive performance (\u03b2\u2009=\u2009\u22120.31, p\u2009=\u20090.016) and reduced processing speed (\u03b2\u2009=\u2009\u22120.40, p\u2009=\u20090.008). Patients with increased sNfL levels had a longer disease duration (p\u2009=\u20090.016), also linked to poorer cognitive outcome (\u03b2\u2009=\u2009\u22120.26, p\u2009=\u20090.045).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In this CIDP cohort, high sNfL levels were associated with reduced cognitive performance and longer disease duration. The findings suggest that sNfL is a clinical meaningful biomarker for the detection and monitoring of central involvement in the course of CIDP, a condition traditionally viewed as purely peripheral.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00415-025-13179-w","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T11:00:25Z","timestamp":1748948425000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Inverse relation between serum neurofilament light chain and cognitive function in chronic inflammatory demyelinating polyneuropathy"],"prefix":"10.1007","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6807-9534","authenticated-orcid":false,"given":"Rohat","family":"Geran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver L.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Krasivskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Hannemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Klostermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"issue":"11","key":"13179_CR1","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1111\/ene.14959","volume":"28","author":"PYK Van den Bergh","year":"2021","unstructured":"Van den Bergh PYK, van Doorn PA, Hadden RDM, Avau B, Vankrunkelsven P, Allen JA et al (2021) European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision. Eur J Neurol 28(11):3556\u20133583. https:\/\/doi.org\/10.1111\/ene.14959","journal-title":"Eur J Neurol"},{"issue":"23","key":"13179_CR2","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1212\/wnl.0000000000006625","volume":"91","author":"H Koike","year":"2018","unstructured":"Koike H, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Katsuno M, Sobue G (2018) Ultrastructural mechanisms of macrophage-induced demyelination in CIDP. Neurology 91(23):1051\u20131060. https:\/\/doi.org\/10.1212\/wnl.0000000000006625","journal-title":"Neurology"},{"issue":"4","key":"13179_CR3","doi-asserted-by":"publisher","first-page":"fcae206","DOI":"10.1093\/braincomms\/fcae206","volume":"6","author":"OL Steiner","year":"2024","unstructured":"Steiner OL, Klostermann F (2024) Central involvement in peripheral disease: melanopsin pathway impairment in chronic inflammatory demyelinating polyneuropathy. Brain Commun 6(4):fcae206. https:\/\/doi.org\/10.1093\/braincomms\/fcae206","journal-title":"Brain Commun"},{"issue":"8","key":"13179_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2712","volume":"12","author":"KL Gable","year":"2022","unstructured":"Gable KL, Peric S, Lutz MW, Bozovic I, Petrovic M, Stojanov A et al (2022) A longitudinal evaluation of fatigue in chronic inflammatory demyelinating polyneuropathy. Brain Behav 12(8):e2712. https:\/\/doi.org\/10.1002\/brb3.2712","journal-title":"Brain Behav"},{"issue":"3\u20134","key":"13179_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000445347","volume":"75","author":"IS Merkies","year":"2016","unstructured":"Merkies IS, Kieseier BC (2016) Fatigue, pain, anxiety and depression in Guillain-Barr\u00e9 Syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. Eur Neurol 75(3\u20134):199\u2013206. https:\/\/doi.org\/10.1159\/000445347","journal-title":"Eur Neurol"},{"issue":"1","key":"13179_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16053","volume":"31","author":"H Lochmann","year":"2024","unstructured":"Lochmann H, Wyrobnik M, Kupper C, Rewitzer C, Klostermann F (2024) Theory of mind and executive dysfunction in chronic inflammatory demyelinating polyneuropathy. Eur J Neurol 31(1):e16053. https:\/\/doi.org\/10.1111\/ene.16053","journal-title":"Eur J Neurol"},{"issue":"10","key":"13179_CR7","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1055\/s-0042-1758557","volume":"80","author":"I Senem","year":"2022","unstructured":"Senem I, Spedo CT, Conde RM, Reis GCD, Santos ACD, Barreira AA, Marques W Jr (2022) Processing speed impairment in chronic inflammatory demyelinating polyneuropathy patients: a cross-sectional study. Arq Neuropsiquiatr 80(10):1036\u20131044. https:\/\/doi.org\/10.1055\/s-0042-1758557","journal-title":"Arq Neuropsiquiatr"},{"issue":"2","key":"13179_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228679","volume":"15","author":"Y Yalachkov","year":"2020","unstructured":"Yalachkov Y, Uhlmann V, Bergmann J, Soyda\u015f D, Frisch S, Behrens M et al (2020) Patients with chronic autoimmune demyelinating polyneuropathies exhibit cognitive deficits which might be associated with CSF evidence of blood-brain barrier disturbance. PLoS ONE 15(2):e0228679. https:\/\/doi.org\/10.1371\/journal.pone.0228679","journal-title":"PLoS ONE"},{"key":"13179_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021254","author":"M Luigetti","year":"2024","unstructured":"Luigetti M, Primiano G, Basile V, Vitali F, Pignalosa S, Romano A et al (2024) Serum neurofilament and free light chain levels in patients undergoing treatment for chronic inflammatory demyelinating polyneuropathy. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25021254","journal-title":"Int J Mol Sci"},{"issue":"10","key":"13179_CR10","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1007\/s00415-021-10537-2","volume":"268","author":"Y Fukami","year":"2021","unstructured":"Fukami Y, Iijima M, Koike H, Yamada S, Hashizume A, Katsuno M (2021) Association of serum neurofilament light chain levels with clinicopathology of chronic inflammatory demyelinating polyneuropathy, including NF155 reactive patients. J Neurol 268(10):3835\u20133844. https:\/\/doi.org\/10.1007\/s00415-021-10537-2","journal-title":"J Neurol"},{"issue":"11","key":"13179_CR11","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1111\/ene.15496","volume":"29","author":"M Kapoor","year":"2022","unstructured":"Kapoor M, Carr A, Foiani M, Heslegrave A, Zetterberg H, Malaspina A et al (2022) Association of plasma neurofilament light chain with disease activity in chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 29(11):3347\u20133357. https:\/\/doi.org\/10.1111\/ene.15496","journal-title":"Eur J Neurol"},{"issue":"13","key":"13179_CR12","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1177\/1352458519881428","volume":"26","author":"D Jakimovski","year":"2020","unstructured":"Jakimovski D, Zivadinov R, Ramanthan M, Hagemeier J, Weinstock-Guttman B, Tomic D et al (2020) Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: a longitudinal retrospective 5-year study. Mult Scler 26(13):1670\u20131681. https:\/\/doi.org\/10.1177\/1352458519881428","journal-title":"Mult Scler"},{"issue":"2","key":"13179_CR13","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1177\/13524585221137697","volume":"29","author":"C Barro","year":"2023","unstructured":"Barro C, Healy BC, Saxena S, Glanz BI, Paul A, Polgar-Turcsanyi M et al (2023) Serum NfL but not GFAP predicts cognitive decline in active progressive multiple sclerosis patients. Mult Scler 29(2):206\u2013211. https:\/\/doi.org\/10.1177\/13524585221137697","journal-title":"Mult Scler"},{"issue":"1","key":"13179_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/brain\/awad267","volume":"147","author":"Y Jung","year":"2024","unstructured":"Jung Y, Damoiseaux JS (2024) The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer\u2019s disease. Brain 147(1):12\u201325. https:\/\/doi.org\/10.1093\/brain\/awad267","journal-title":"Brain"},{"issue":"12","key":"13179_CR15","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1002\/mds.28779","volume":"36","author":"WW Aamodt","year":"2021","unstructured":"Aamodt WW, Waligorska T, Shen J, Tropea TF, Siderowf A, Weintraub D et al (2021) Neurofilament light chain as a biomarker for cognitive decline in Parkinson Disease. Mov Disord 36(12):2945\u20132950. https:\/\/doi.org\/10.1002\/mds.28779","journal-title":"Mov Disord"},{"key":"13179_CR16","doi-asserted-by":"publisher","first-page":"117229","DOI":"10.1016\/j.jns.2020.117229","volume":"420","author":"S Ramani","year":"2021","unstructured":"Ramani S, Berard JA, Walker LAS (2021) The relationship between neurofilament light chain and cognition in neurological disorders: a scoping review. J Neurol Sci 420:117229. https:\/\/doi.org\/10.1016\/j.jns.2020.117229","journal-title":"J Neurol Sci"},{"key":"13179_CR17","doi-asserted-by":"publisher","unstructured":"American Psychiatric A. Diagnostisches und Statistisches Manual Psychischer St\u00f6rungen DSM-5\u00ae : Deutsche Ausgabe herausgegeben von Peter Falkai und Hans-Ulrich Wittchen, mitherausgegeben von Manfred D\u00f6pfner, Wolfgang Gaebel, Wolfgang Maier, Winfried Rief, Henning Sa\u00df und Michael Zaudig: Hogrefe Verlag GmbH & Co. KG, 2018 Available from: https:\/\/elibrary.hogrefe.com\/book\/https:\/\/doi.org\/10.1026\/02803-000.","DOI":"10.1026\/02803-000"},{"issue":"4","key":"13179_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1212\/WNL.0b013e318208824b","volume":"76","author":"SI van Nes","year":"2011","unstructured":"van Nes SI, Vanhoutte EK, van Doorn PA, Hermans M, Bakkers M, Kuitwaard K et al (2011) Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies. Neurology 76(4):337\u2013345. https:\/\/doi.org\/10.1212\/WNL.0b013e318208824b","journal-title":"Neurology"},{"key":"13179_CR19","doi-asserted-by":"publisher","first-page":"104177","DOI":"10.1016\/j.msard.2022.104177","volume":"67","author":"KZ Revendova","year":"2022","unstructured":"Revendova KZ, Zeman D, Bunganic R, Karasova K, Volny O, Bar M, Kusnierova P (2022) Serum neurofilament levels in patients with multiple sclerosis: a comparison of SIMOA and high sensitivity ELISA assays and contributing factors to ELISA levels. Mult Scler Relat Disord 67:104177. https:\/\/doi.org\/10.1016\/j.msard.2022.104177","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"13179_CR20","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nbt.1641","volume":"28","author":"DM Rissin","year":"2010","unstructured":"Rissin DM, Kan CW, Campbell TG, Howes SC, Fournier DR, Song L et al (2010) Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat Biotechnol 28(6):595\u2013599. https:\/\/doi.org\/10.1038\/nbt.1641","journal-title":"Nat Biotechnol"},{"issue":"3","key":"13179_CR21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/s1474-4422(22)00009-6","volume":"21","author":"P Benkert","year":"2022","unstructured":"Benkert P, Meier S, Schaedelin S, Manouchehrinia A, Yaldizli \u00d6, Maceski A et al (2022) Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study. Lancet Neurol 21(3):246\u2013257. https:\/\/doi.org\/10.1016\/s1474-4422(22)00009-6","journal-title":"Lancet Neurol"},{"key":"13179_CR22","volume-title":"An R companion to applied regression","author":"J Fox","year":"2019","unstructured":"Fox J, Weisberg S (2019) An R companion to applied regression. 3rd ed. SAGE Publications, Thousand Oaks, CA","edition":"3"},{"issue":"1","key":"13179_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v095.i01","volume":"95","author":"A Zeileis","year":"2020","unstructured":"Zeileis A, K\u00f6ll S, Graham N (2020) Various versatile variances: an object-oriented implementation of clustered covariances in R. J Stat Softw 95(1):1\u201336. https:\/\/doi.org\/10.18637\/jss.v095.i01","journal-title":"J Stat Softw"},{"issue":"4","key":"13179_CR24","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3758\/BF03192961","volume":"39","author":"AF Hayes","year":"2007","unstructured":"Hayes AF, Cai L (2007) Using heteroskedasticity-consistent standard error estimators in OLS regression: an introduction and software implementation. Behav Res Methods 39(4):709\u2013722. https:\/\/doi.org\/10.3758\/BF03192961","journal-title":"Behav Res Methods"},{"issue":"4","key":"13179_CR25","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1214\/ss\/1009212519","volume":"14","author":"JA Hoeting","year":"1999","unstructured":"Hoeting JA, Madigan D, Raftery AE, Volinsky CT (1999) Bayesian model averaging: a tutorial. Stat Sci 14(4):382\u2013401. https:\/\/doi.org\/10.1214\/ss\/1009212519","journal-title":"Stat Sci"},{"issue":"3","key":"13179_CR26","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1214\/009053604000000238","volume":"32","author":"MM Barbieri","year":"2004","unstructured":"Barbieri MM, Berger JO (2004) Optimal predictive model selection. Ann Stat 32(3):870\u2013897. https:\/\/doi.org\/10.1214\/009053604000000238","journal-title":"Ann Stat"},{"issue":"4","key":"13179_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v068.i04","volume":"68","author":"S Zeugner","year":"2015","unstructured":"Zeugner S, Feldkircher M (2015) Bayesian model averaging employing fixed and flexible priors: the BMS package for R. J Stat Softw 68(4):1\u201337. https:\/\/doi.org\/10.18637\/jss.v068.i04","journal-title":"J Stat Softw"},{"issue":"1","key":"13179_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16023","volume":"31","author":"PL Poser","year":"2024","unstructured":"Poser PL, Sajid GS, Beyer L, Hieke A, Schumacher A, Horstkemper L et al (2024) Serum neurofilament light chain does not detect self-reported treatment-related fluctuations in chronic inflammatory demyelinating polyneuropathy. Eur J Neurol 31(1):e16023. https:\/\/doi.org\/10.1111\/ene.16023","journal-title":"Eur J Neurol"},{"issue":"12","key":"13179_CR29","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1093\/brain\/awaa342","volume":"143","author":"AL Benedet","year":"2020","unstructured":"Benedet AL, Leuzy A, Pascoal TA, Ashton NJ, Mathotaarachchi S, Savard M et al (2020) Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer\u2019s disease. Brain 143(12):3793\u20133804. https:\/\/doi.org\/10.1093\/brain\/awaa342","journal-title":"Brain"},{"key":"13179_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.parkreldis.2020.04.009","volume":"74","author":"F Sampedro","year":"2020","unstructured":"Sampedro F, P\u00e9rez-Gonz\u00e1lez R, Mart\u00ednez-Horta S, Mar\u00edn-Lahoz J, Pagonabarraga J, Kulisevsky J (2020) Serum neurofilament light chain levels reflect cortical neurodegeneration in de novo Parkinson\u2019s disease. Parkinsonism Relat Disord 74:43\u201349. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.04.009","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"13179_CR31","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1111\/ene.15742","volume":"30","author":"A Buchmann","year":"2023","unstructured":"Buchmann A, Pirpamer L, Pinter D, Voortman M, Helmlinger B, Pichler A et al (2023) High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis. Eur J Neurol 30(5):1389\u20131399. https:\/\/doi.org\/10.1111\/ene.15742","journal-title":"Eur J Neurol"},{"issue":"2","key":"13179_CR32","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1136\/jnnp-2023-331784","volume":"95","author":"E Longinetti","year":"2024","unstructured":"Longinetti E, Englund S, Burman J, Fink K, Fogdell-Hahn A, Gunnarsson M et al (2024) Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy. J Neurol Neurosurg Psychiatry 95(2):134\u2013141. https:\/\/doi.org\/10.1136\/jnnp-2023-331784","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"13179_CR33","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/s1474-4422(20)30277-5","volume":"19","author":"RHB Benedict","year":"2020","unstructured":"Benedict RHB, Amato MP, DeLuca J, Geurts JJG (2020) Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues. Lancet Neurol 19(10):860\u2013871. https:\/\/doi.org\/10.1016\/s1474-4422(20)30277-5","journal-title":"Lancet Neurol"},{"issue":"8","key":"13179_CR34","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1007\/s00415-020-09832-1","volume":"267","author":"F Mattioli","year":"2020","unstructured":"Mattioli F, Bellomi F, Stampatori C, Mariotto S, Ferrari S, Monaco S et al (2020) Longitudinal serum neurofilament light chain (sNfL) concentration relates to cognitive function in multiple sclerosis patients. J Neurol 267(8):2245\u20132251. https:\/\/doi.org\/10.1007\/s00415-020-09832-1","journal-title":"J Neurol"},{"issue":"3","key":"13179_CR35","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1017\/s1355617722000157","volume":"29","author":"M Pitteri","year":"2023","unstructured":"Pitteri M, Dapor C, DeLuca J, Chiaravalloti ND, Marastoni D, Calabrese M (2023) Slowing processing speed is associated with cognitive fatigue in newly diagnosed multiple sclerosis patients. J Int Neuropsychol Soc 29(3):283\u2013289. https:\/\/doi.org\/10.1017\/s1355617722000157","journal-title":"J Int Neuropsychol Soc"},{"issue":"1","key":"13179_CR36","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1177\/1352458506071196","volume":"13","author":"L Feuillet","year":"2007","unstructured":"Feuillet L, Reuter F, Audoin B, Malikova I, Barrau K, Cherif AA, Pelletier J (2007) Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 13(1):124\u2013127. https:\/\/doi.org\/10.1177\/1352458506071196","journal-title":"Mult Scler"},{"key":"13179_CR37","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3389\/fneur.2017.00724","volume":"8","author":"J Klehmet","year":"2017","unstructured":"Klehmet J, Staudt M, Diederich JM, Siebert E, Meinl E, Harms L, Meisel A (2017) Neurofascin (NF)155- and NF186-Specific T Cell Response in a patient developing a central pontocerebellar demyelination after 10 years of CIDP. Front Neurol 8:724. https:\/\/doi.org\/10.3389\/fneur.2017.00724","journal-title":"Front Neurol"},{"issue":"8","key":"13179_CR38","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1212\/WNL.0b013e3182a1aa9c","volume":"81","author":"N Kawamura","year":"2013","unstructured":"Kawamura N, Yamasaki R, Yonekawa T, Matsushita T, Kusunoki S, Nagayama S et al (2013) Anti-neurofascin antibody in patients with combined central and peripheral demyelination. Neurology 81(8):714\u2013722. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a1aa9c","journal-title":"Neurology"},{"issue":"8","key":"13179_CR39","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1212\/wnl.53.8.1648","volume":"53","author":"IS Merkies","year":"1999","unstructured":"Merkies IS, Schmitz PI, Samijn JP, van der Mech\u00e9 FG, van Doorn PA (1999) Fatigue in immune-mediated polyneuropathies. European inflammatory neuropathy cause and treatment (INCAT) group. Neurology 53(8):1648\u20131654. https:\/\/doi.org\/10.1212\/wnl.53.8.1648","journal-title":"Neurology"},{"key":"13179_CR40","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.3389\/fimmu.2019.01696","volume":"10","author":"CH Lee","year":"2019","unstructured":"Lee CH, Giuliani F (2019) The role of inflammation in depression and fatigue. Front Immunol 10:1696. https:\/\/doi.org\/10.3389\/fimmu.2019.01696","journal-title":"Front Immunol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13179-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13179-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13179-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T13:24:41Z","timestamp":1749907481000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13179-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["13179"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13179-w","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Fabian Klostermann received honoraria for lecturing and advisory activities, unrelated to the presented research, from Abbvie, Stadapharm, Esteve, CSL Behring, and Takeda.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Patients provided written consent for the publication of anonymization data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"439"}}